November 26, 2015
Recommended Topic Related To:

Retrovir IV

"The European Medicines Agency (EMA) has updated information on the risk for body fat changes and lactic acidosis associated with antiretroviral medications for HIV infection.

HIV medicines will no longer require a warning regarding fa"...

Retrovir IV



Acute overdoses of zidovudine have been reported in pediatric patients and adults. These involved exposures up to 50 grams. No specific symptoms or signs have been identified following acute overdosage with zidovudine apart from those listed as adverse events such as fatigue, headache, vomiting, and occasional reports of hematological disturbances. All patients recovered without permanent sequelae. Hemodialysis and peritoneal dialysis appear to have a negligible effect on the removal of zidovudine, while elimination of its primary metabolite, GZDV, is enhanced.


RETROVIR IV (zidovudine injection) Infusion is contraindicated for patients who have potentially life-threatening allergic reactions to any of the components of the formulation.

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 4/29/2009


Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

WebMD Daily

Get breaking medical news.